Movano (MOVE) has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable. The study, which ...

Among patients with suspected or confirmed glaucoma, higher average blood pressure and greater variability in blood pressure ...

Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist ...

Many treatments exist to minimize the effects of cardiovascular disease on quality of life and longevity but, an ounce of ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

Arterial health is essential for overall well-being and the prevention of cardiovascular disease. Dr. Michael Twyman, a ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

The allure of crispy, golden-brown fried foods continues to influence dietary choices worldwide, despite mounting evidence ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people ...

A new molecular imaging technique-18F-FAPI PET-can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker ...

The accuracy study criteria for the comparisons between the systolic, diastolic, and MAP values from the noninvasive blood pressure monitor and the intra-arterial blood pressure reference standard ...

Explore the hidden dynamics of heart disease, its risks, and how new strategies and innovations help improve heart health ...